Clinical Trial Update: Study to Determine the Response and Effectiveness of RSD1235 in Subjects With Atrial Fibrillation or Atrial Flutter [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the response and effectiveness of RSD1235 in patients with atrial fibrillation or atrial flutter has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter

Drugs mentioned

• RSD1235

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Atrial Flutter, Atrial Fibrillation | Phase 3 | Status: COMPLETED